Nektar Therapeutics (NASDAQ:NKTR) is one of the best hot stocks to buy according to Wall Street analysts. On June 24, Nektar ...

A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch ...

Doctors report a steady increase in eczema cases among infants across Indian cities. Experts warn that genetics and ...

Figure skater Michelle Hong used to hide her skin as much as possible due to her condition—but with effective treatment and ...

The ulcer grew. In fact, it seemed as though his leg was caving in as the flesh around it began rotting away. A month before ...

In this video, Robert J. Smith, MD, discusses the many treatment options available to patients with atopic dermatitis.

Nektar Therapeutics shares doubled in early trading Tuesday after the U.S. biotech firm said it reached its targets in a midstage study of its eczema treatment.

Learn how Dupixent helps diverse eczema patients and why inclusive clinical trials are vital for fair healthcare.

Any physical activity can be beneficial for eczema, as long as you’re choosing the right clothing and practicing good habits ...

The latest biotech stock to explode in price, Nektar Therapeutics (NASDAQ: NKTR) was quite the outperformer on the stock ...

Nektar, which accused Lilly of making errors in its analysis of the data, forged ahead with the programme and started the ...

Nektar Therapeutics (NKTR) saw its stock surge 86% Tuesday morning after reporting strong midstage trial results for its ...